Volume 124, Issue 6 , Pages 1197-1203, December 2009
Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall
Full Text Available
Supported by GlaxoSmithKline, Research Triangle Park, NC.
Disclosure of potential conflict of interest: R. H. Stanford and D. A. Stempel are employees of GlaxoSmithKline. J. Spahn has received honoraria and served as a consultant for GlaxoSmithKline, has received research support from Merck, and has served as an expert witness for GlaxoSmithKline. K. Sheth has received honoraria from Alcon, AstraZeneca, and Sanofi; has served as a consultant for Sepracor (Altana); and has received honoraria and served as a consultant for GlaxoSmithKline. W.-S. Yeh has received consulting fees from GlaxoSmithKline.
PII: S0091-6749(09)01325-6
doi:10.1016/j.jaci.2009.08.042
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 124, Issue 6 , Pages 1197-1203, December 2009

